Medications

Teva stops selling migraine patch after reports of burns

Teva Pharmaceutical said Monday that it will stop selling its migraine patch treatment Zecuity after users reported burns and scars where it was applied. The company advised that anyone who has its patch should not use it.

Oncology & Cancer

Mutation V60L increases predisposition to skin cancer

When Homo sapiens left Africa and had to adapt to less sunny climates, there was a mutation in one of the genes responsible for regulating the synthesis of melanin, the MC1R gene, which involved a discoloration of the skin. ...

Diseases, Conditions, Syndromes

AAD: Skin changes can be first sign of underlying condition

(HealthDay)—Skin changes, including new rash, new growths, discoloration, and changes in texture, could be among the first signs indicating an underlying medical condition, according to information presented at the annual ...

Other

Girl to get $10M for amputations after ER delay

(AP) -- The family of a California girl whose extremities were amputated because of a lengthy emergency room delay has agreed to a $10 million malpractice settlement.